![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print September 9, 2004
Division of Cell Biology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121
Corresponding Author: toshi{at}liai.org
Akt (= protein kinase B), a subfamily of the AGC serine/threonine kinases, plays critical roles in survival, proliferation, glucose metabolism, and other cellular functions. Akt activation requires the recruitment of the enzyme to the plasma membrane by interacting with membrane-bound lipid products of phosphatidylinositol 3-kinase. Membrane-bound Akt is then phosphorylated at two sites for its full activation: Thr-308 in the activation loop of the kinase domain is phosphorylated by 3-phosphoinositide-dependent kinase-1 (PDK1) and Ser-473 in the C-terminal hydrophobic motif by a putative kinase PDK2. The identity of PDK2 has been elusive. Here we present evidence that conventional isoforms of protein kinase C (PKC), particularly PKC
J. Biol. Chem, 10.1074/jbc.M408797200
Submitted on August 2, 2004
Revised on September 8, 2004
Accepted on September 9, 2004
Protein kinase C
II regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion
II, can regulate Akt activity by directly phosphorylating Ser-473 in vitro and in IgE/antigen-stimulated mast cells. By contrast, PKC
is not required for Ser-473 phosphorylation in mast cells stimulated with stem cell factor or IL-3, in serum-stimulated fibroblasts, or in antigen receptor-stimulated T or B lymphocytes. Therefore, PKC
II appears to work as a cell type- and stimulus-specific PDK2.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Ono, H. Sakoda, M. Fujishiro, M. Anai, A. Kushiyama, Y. Fukushima, H. Katagiri, T. Ogihara, Y. Oka, H. Kamata, et al. Carboxy-terminal modulator protein induces Akt phosphorylation and activation, thereby enhancing antiapoptotic, glycogen synthetic, and glucose uptake pathways Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1576 - C1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Khundmiri, V. Amin, J. Henson, J. Lewis, M. Ameen, M. J. Rane, and N. A. Delamere Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1171 - C1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Herbst, Y. Oh, A. Wagle, and M. Lahn Enzastaurin, a Protein Kinase C{beta} Selective Inhibitor, and Its Potential Application as an Anticancer Agent in Lung Cancer Clin. Cancer Res., August 1, 2007; 13(15): 4641s - 4646s. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Preiss, D. Namgaladze, and B. Brune Critical role for classical PKC in activating Akt by phospholipase A2-modified LDL in monocytic cells Cardiovasc Res, March 1, 2007; 73(4): 833 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Masuda, K. Hashimoto, T. Yokoi, T. Doi, T. Kodama, H. Kume, K. Ohno, and T. Matsuguchi Essential Role of GATA Transcriptional Factors in the Activation of Mast Cells J. Immunol., January 1, 2007; 178(1): 360 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshizaki, N. Mochizuki, Y. Gotoh, and M. Matsuda Akt-PDK1 Complex Mediates Epidermal Growth Factor-induced Membrane Protrusion through Ral Activation Mol. Biol. Cell, January 1, 2007; 18(1): 119 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Barragan, M. de Frias, D. Iglesias-Serret, C. Campas, E. Castano, A. F. Santidrian, L. Coll-Mulet, A. M. Cosialls, A. Domingo, G. Pons, et al. Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta} J. Leukoc. Biol., December 1, 2006; 80(6): 1473 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Patke, I. Mecklenbrauker, H. Erdjument-Bromage, P. Tempst, and A. Tarakhovsky BAFF controls B cell metabolic fitness through a PKC{beta}- and Akt-dependent mechanism J. Exp. Med., October 30, 2006; 203(11): 2551 - 2562. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Ludowyke, Z. Elgundi, T. Kranenburg, J. R. Stehn, C. Schmitz-Peiffer, W. E. Hughes, and T. J. Biden Phosphorylation of Nonmuscle Myosin Heavy Chain IIA on Ser1917 Is Mediated by Protein Kinase CbetaII and Coincides with the Onset of Stimulated Degranulation of RBL-2H3 Mast Cells J. Immunol., August 1, 2006; 177(3): 1492 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lu, F. Kambe, X. Cao, T. Yoshida, S. Ohmori, K. Murakami, T. Kaji, T. Ishii, D. Zadworny, and H. Seo DHCR24-Knockout Embryonic Fibroblasts Are Susceptible to Serum Withdrawal-Induced Apoptosis Because of Dysfunction of Caveolae and Insulin-Akt-Bad Signaling Endocrinology, June 1, 2006; 147(6): 3123 - 3132. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fayard, L. A. Tintignac, A. Baudry, and B. A. Hemmings Protein kinase B/Akt at a glance J. Cell Sci., December 15, 2005; 118(24): 5675 - 5678. [Full Text] [PDF] |
||||
![]() |
G. Boden, P. She, M. Mozzoli, P. Cheung, K. Gumireddy, P. Reddy, X. Xiang, Z. Luo, and N. Ruderman Free Fatty Acids Produce Insulin Resistance and Activate the Proinflammatory Nuclear Factor-{kappa}B Pathway in Rat Liver Diabetes, December 1, 2005; 54(12): 3458 - 3465. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gomez, C. Gonzalez-Espinosa, S. Odom, G. Baez, M. E. Cid, J. J. Ryan, and J. Rivera Impaired Fc{epsilon}RI-Dependent Gene Expression and Defective Eicosanoid and Cytokine Production as a Consequence of Fyn Deficiency in Mast Cells J. Immunol., December 1, 2005; 175(11): 7602 - 7610. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, K. Furuta, R. Teshima, N. Shirata, Y. Sugimoto, A. Ichikawa, and S. Tanaka Critical Role of Protein Kinase C {beta}II in Activation of Mast Cells by Monomeric IgE J. Biol. Chem., November 25, 2005; 280(47): 38976 - 38981. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Graff, A. M. McNulty, K. R. Hanna, B. W. Konicek, R. L. Lynch, S. N. Bailey, C. Banks, A. Capen, R. Goode, J. E. Lewis, et al. The Protein Kinase C{beta}-Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts Cancer Res., August 15, 2005; 65(16): 7462 - 7469. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Q. Dong and F. Liu PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E187 - E196. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Feldman, J. M. Wu, M. A. Polokoff, M. J. Kochanny, H. Dinter, D. Zhu, S. L. Biroc, B. Alicke, J. Bryant, S. Yuan, et al. Novel Small Molecule Inhibitors of 3-Phosphoinositide-dependent Kinase-1 J. Biol. Chem., May 20, 2005; 280(20): 19867 - 19874. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kitaura, K. Eto, T. Kinoshita, Y. Kawakami, M. Leitges, C. A. Lowell, and T. Kawakami Regulation of Highly Cytokinergic IgE-Induced Mast Cell Adhesion by Src, Syk, Tec, and Protein Kinase C Family Kinases J. Immunol., April 15, 2005; 174(8): 4495 - 4504. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shin, J. Edl, S. Biswas, P. C. Lin, R. Mernaugh, and C. L. Arteaga Proapoptotic Activity of Cell-Permeable Anti-Akt Single-Chain Antibodies Cancer Res., April 1, 2005; 65(7): 2815 - 2824. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |